Mergers and Acquisitions
You are here: Home : Topics A-Z : Mergers and Acquisitions
Follow this topic
- Subscribe to our Mergers and Acquisitions RSS feed
-
Want to Add a Decade of Cash Flow? Buy It
By acquiring WellPoint's pharmacy benefits business, Express Scripts added 25 million new clients, CFO Jeff Hall says. April 15, 2009
-
Behind the Eight Ball, Brunswick Scratches on Tax Case
Last year, a court upheld the government's interpretation of an old depreciation-related rule against Brunswick Corporation, which may affect other companies that chose a stock purchase over an asset purchase. April 6, 2009
-
Deal With It
Banks aren't lending, investor defaults are looming, and mark-to-market is a pain. But private equity CFOs are forging a path through the downturn. April 2, 2009
-
Deals: There Will Be Oil ... in Calgary, Anyway
In our M&A Roundup for the week ended March 29, Suncor's $18.39-billion purchase of Petro-Canada tops the sale of Calgary-based Oilexco's North Sea assets. Deloitte, Time Warner also do some buying. March 30, 2009
-
U.S. Shareholders Grab Foreign Merger Tax Benefit
The deal that marries Petro-Canada and Suncor will deliver tax-free treatment to U.S. investors. March 30, 2009
-
Deals: Fertilizer, Roller Coasters, and Gold
In our M&A Roundup for the week ended March 22, a diverse lot of billion-dollar deals helps keep the totals respectable — though far short of the prior "Merck Week." March 23, 2009
-
Break for the Press: IRS Allows Tax-free Intangibles Swap
After a change of heart by the tax service, businesses — including troubled newspapers — will be able to separate certain intangible assets from goodwill in transactions. March 19, 2009
-
Gathering Clouds
Information technology: The takeover talks between IBM and Sun highlight a shift in the industry. March 19, 2009
-
Deals: Pharma Is the Cure for M&A's Blahs
In our M&A Roundup for the week ended March 15, Merck-Schering is followed — at a distance — by Gilead Sciences buying CV Therapeutics. Behind them, an eclectic mix. March 16, 2009
-
Merck's "Unusual" Deal Moves Beyond Taxes
The reverse merger between Merck and Schering-Plough was not done to garner tax-free status - although it will - but to maintain a business relationship with J&J. March 16, 2009
Related White Papers
advertisement
Business Solutions Center
advertisement


Video